И. М. Марусенко

595 total citations
18 papers, 58 citations indexed

About

И. М. Марусенко is a scholar working on Rheumatology, Immunology and Oncology. According to data from OpenAlex, И. М. Марусенко has authored 18 papers receiving a total of 58 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Rheumatology, 5 papers in Immunology and 4 papers in Oncology. Recurrent topics in И. М. Марусенко's work include Rheumatoid Arthritis Research and Therapies (8 papers), Healthcare Systems and Public Health (3 papers) and Cytokine Signaling Pathways and Interactions (3 papers). И. М. Марусенко is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (8 papers), Healthcare Systems and Public Health (3 papers) and Cytokine Signaling Pathways and Interactions (3 papers). И. М. Марусенко collaborates with scholars based in Russia, United States and Belarus. И. М. Марусенко's co-authors include Н. Н. Везикова, D. G. Krechikova, O. B. Nesmeyanova, Alexey V. Churov, О.Н. Иванова, Е. К. Олейник, E L Nasonov, Mazurov Vi, Н. Н. Немова and Е. В. Зонова and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Bulletin of Experimental Biology and Medicine.

In The Last Decade

И. М. Марусенко

13 papers receiving 54 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
И. М. Марусенко Russia 5 23 20 9 6 5 18 58
Н. Н. Везикова Russia 5 13 0.6× 11 0.6× 8 0.9× 1 0.2× 4 0.8× 23 47
Sheng Kuo United States 3 16 0.7× 8 0.4× 7 0.8× 14 2.3× 5 1.0× 4 59
Zahraa I. Selim Egypt 5 16 0.7× 34 1.7× 6 0.7× 8 1.3× 6 1.2× 12 64
Domenico Olivo Italy 5 9 0.4× 45 2.3× 10 1.1× 9 1.5× 3 0.6× 8 76
Helena Viana Portugal 6 8 0.3× 19 0.9× 5 0.6× 7 1.2× 5 1.0× 32 59
Frank Glavin United States 5 14 0.6× 30 1.5× 4 0.4× 3 0.5× 4 0.8× 6 63
Özlem Özkul Türkiye 6 14 0.6× 10 0.5× 13 1.4× 4 0.7× 13 2.6× 12 76
Prashant Tripathi India 5 5 0.2× 6 0.3× 8 0.9× 7 1.2× 11 2.2× 26 64
Helena Skálová Czechia 5 19 0.8× 7 0.3× 5 0.6× 7 1.2× 13 2.6× 8 82
Nobuhiro Ido Japan 5 29 1.3× 4 0.2× 7 0.8× 13 2.2× 10 2.0× 6 134

Countries citing papers authored by И. М. Марусенко

Since Specialization
Citations

This map shows the geographic impact of И. М. Марусенко's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by И. М. Марусенко with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites И. М. Марусенко more than expected).

Fields of papers citing papers by И. М. Марусенко

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by И. М. Марусенко. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by И. М. Марусенко. The network helps show where И. М. Марусенко may publish in the future.

Co-authorship network of co-authors of И. М. Марусенко

This figure shows the co-authorship network connecting the top 25 collaborators of И. М. Марусенко. A scholar is included among the top collaborators of И. М. Марусенко based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with И. М. Марусенко. И. М. Марусенко is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Марусенко, И. М., et al.. (2021). Difficulties in the diagnosis and treatment of comorbid infections with rheumatoid arthritis. Case report. Terapevticheskii arkhiv. 93(5). 71516–71516.
2.
3.
Каратеев, А. Е., Е. С. Филатова, Е. Л. Насонов, et al.. (2020). THU0206 А VERY EARLY (7-28 DAYS) RESPONSE ON JAK INHIBITOR TOFACITINIB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: EFFECT ON PAIN AND CENTRAL SENSITIZATION.. Annals of the Rheumatic Diseases. 79. 327–327. 1 indexed citations
4.
Марусенко, И. М., et al.. (2020). Diabetes mellitus in patients with rheumatoid arthritis in the Republic of Karelia. SHILAP Revista de lepidopterología. 14(2). 57–61. 1 indexed citations
5.
Каратеев, А. Е., et al.. (2019). Rheumatoid arthritis in real clinical practice. Results of the «Computer Terminals of Self-Assessment for Patients with Rheumatic Diseases» («TERMINAL-I») project. SHILAP Revista de lepidopterología. 13(2). 25–30. 1 indexed citations
6.
Марусенко, И. М., et al.. (2018). DICER and DROSHA gene expression in peripheral mononuclear blood cells from rheumatoid arthritis patients under methotrexate therapy. Terapevticheskii arkhiv. 90(5). 72–75.
7.
Марусенко, И. М., et al.. (2018). Analysis of the Association of TNF -238G>A Gene Polymorphism with the Risk of Rheumatoid Arthritis Development in Russian Population in the Republic of Karelia. Bulletin of Experimental Biology and Medicine. 165(5). 674–677. 2 indexed citations
8.
9.
Марусенко, И. М., et al.. (2017). OCCURRENCE OF THE METABOLIC SYNDROME AND ITS EFFECT ON CARDIOVASCULAR RISK IN PATIENTS WITH GOUT. Rational Pharmacotherapy in Cardiology. 13(4). 476–481.
10.
Марусенко, И. М., et al.. (2017). HYPERTHYROIDISM AND ATRIAL FIBRILLATION. Rational Pharmacotherapy in Cardiology. 13(3). 398–402. 4 indexed citations
11.
Везикова, Н. Н., et al.. (2016). The level of cytokines and expression of caspase genes in rheumatoid arthritis. Doklady Biochemistry and Biophysics. 468(1). 226–228. 9 indexed citations
12.
Nasonov, E L, Е. В. Зонова, О.Н. Иванова, et al.. (2016). THE RESULTS OF A PHASE III COMPARATIVE CLINICAL TRIAL OF RITUXIMAB (ACELLBIA® AND MABTHERA®) IN RHEUMATOID ARTHRITIS (THE BIORA STUDY). Rheumatology Science and Practice. 54(5). 510–519. 21 indexed citations
13.
Churov, Alexey V., et al.. (2016). Subpopulations of regulatory T-lymphocytes in the peripheral blood of patients with rheumatoid arthritis. Annals of the Russian academy of medical sciences. 71(2). 148–153. 10 indexed citations
14.
Везикова, Н. Н., et al.. (2016). CORRELATION OF INFLAMMATION BIOMARKERS WITH THE TRADITIONAL RISK FACTORS IN PATIENTS WITH ACUTE CORONARY SYNDROME. Rational Pharmacotherapy in Cardiology. 12(2). 166–170. 1 indexed citations
15.
16.
Марусенко, И. М., et al.. (2009). SECONDARY AMYLOIDOSIS WITH LUNG INVOLVEMENT INA FEMALE PATIENT WITH RHEUMATOID ARTHRITIS. Modern Rheumatology Journal. 0(3). 50–50.
17.
Марусенко, И. М., et al.. (2009). Features of diagnosis and treatment of anemic syndrome in patients with rheumatoid arthritis. Rheumatology Science and Practice. 0(6). 26–26. 1 indexed citations
18.
Везикова, Н. Н., et al.. (2007). [Osteogenon in therapy of distal radial bone fractures in patients with secondary osteoporosis].. PubMed. 79(3). 52–4. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Н. Н. Везикова Breakdown of academic impact, for papers by Sheng Kuo Breakdown of academic impact, for papers by Zahraa I. Selim Breakdown of academic impact, for papers by Domenico Olivo Breakdown of academic impact, for papers by Helena Viana Breakdown of academic impact, for papers by Frank Glavin Breakdown of academic impact, for papers by Özlem Özkul Breakdown of academic impact, for papers by Prashant Tripathi Breakdown of academic impact, for papers by Helena Skálová Breakdown of academic impact, for papers by Nobuhiro Ido
Rankless by CCL
2026